Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Pathway Database and Analysis Products to Procter & Gamble Pharmaceuticals

NEW YORK, May 9 (GenomeWeb News) - GeneGo has licensed its MetaCore and MetaBase pathway database and analysis products to Procter & Gamble Pharmaceuticals, a subsidiary of Procter & Gamble, the St. Joseph, Mich.-based company said today.


MetaBase is a manually curated database with information on mammalian signaling, metabolism, transcription factors, receptors, drug targets, and bioactive chemistry. MetaCore allows users to examine multiple types of data in parallel and to edit pathways and add annotations.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.